270 results
Page 8 of 14
8-K
vs80l
10 Aug 21
Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors
4:19pm
8-K
EX-99.1
kogxj2fl m9qo
10 Aug 21
Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors
4:19pm
8-K
vaaof1
5 Aug 21
Departure of Directors or Certain Officers
7:45am
8-K
r3e92f8f2ejn
22 Jun 21
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
EX-99.1
urile473nb lt
19 May 21
Once-daily (QD) dose escalation completed; pharmacokinetic (PK) profile consistent with design principles and preclinical predictions
5:06pm
8-K
u2i4axa g5z50rl3
19 May 21
Once-daily (QD) dose escalation completed; pharmacokinetic (PK) profile consistent with design principles and preclinical predictions
5:06pm
8-K
tkb9 bc1h69i9i3
7 May 21
Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:11am
8-K
EX-99.1
1c3ty4twag0meus
7 May 21
Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:11am
DEFA14A
1ftcqd5ta5ghb1qqlk
29 Apr 21
Additional proxy soliciting materials
4:04pm
DEF 14A
q9n06bw0ee9roxid
27 Apr 21
Definitive proxy
4:06pm
8-K
gwhp33y
21 Apr 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:00am
S-8
EX-5.1
vlifotvqui6z
25 Mar 21
Registration of securities for employees
7:33am
S-8
2gm4zm etevupe6b
25 Mar 21
Registration of securities for employees
7:33am
S-8
EX-23.1
zonrx
25 Mar 21
Registration of securities for employees
7:33am